WO2000014507A1 - Removal of embedding media from biological samples and cell conditioning on automated staining instruments - Google Patents
Removal of embedding media from biological samples and cell conditioning on automated staining instruments Download PDFInfo
- Publication number
- WO2000014507A1 WO2000014507A1 PCT/US1999/020353 US9920353W WO0014507A1 WO 2000014507 A1 WO2000014507 A1 WO 2000014507A1 US 9920353 W US9920353 W US 9920353W WO 0014507 A1 WO0014507 A1 WO 0014507A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- biological sample
- automated method
- applying
- slide
- exposing
- Prior art date
Links
- 239000012472 biological sample Substances 0.000 title claims abstract description 131
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 62
- 238000010186 staining Methods 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 124
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 43
- 239000012530 fluid Substances 0.000 claims abstract description 18
- 238000005530 etching Methods 0.000 claims abstract description 17
- 239000000243 solution Substances 0.000 claims description 48
- 238000010438 heat treatment Methods 0.000 claims description 44
- 239000000872 buffer Substances 0.000 claims description 34
- 239000007979 citrate buffer Substances 0.000 claims description 17
- 239000008367 deionised water Substances 0.000 claims description 13
- -1 Norpar Substances 0.000 claims description 11
- 239000002563 ionic surfactant Substances 0.000 claims description 10
- 239000002736 nonionic surfactant Substances 0.000 claims description 10
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 9
- 239000008363 phosphate buffer Substances 0.000 claims description 9
- 229940083575 sodium dodecyl sulfate Drugs 0.000 claims description 8
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 7
- 239000013504 Triton X-100 Substances 0.000 claims description 7
- 229920004890 Triton X-100 Polymers 0.000 claims description 7
- 230000002378 acidificating effect Effects 0.000 claims description 7
- 239000000828 canola oil Substances 0.000 claims description 7
- 235000019519 canola oil Nutrition 0.000 claims description 7
- 239000002480 mineral oil Substances 0.000 claims description 7
- 235000010446 mineral oil Nutrition 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 229920000136 polysorbate Polymers 0.000 claims description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 7
- 229930182490 saponin Natural products 0.000 claims description 7
- 150000007949 saponins Chemical class 0.000 claims description 7
- 239000003599 detergent Substances 0.000 claims description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 2
- 239000003535 biological staining Substances 0.000 claims 6
- 239000003570 air Substances 0.000 claims 5
- 230000001744 histochemical effect Effects 0.000 abstract description 10
- 230000000093 cytochemical effect Effects 0.000 abstract description 5
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 239000000470 constituent Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 83
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 31
- 239000007788 liquid Substances 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 30
- 239000000523 sample Substances 0.000 description 29
- 239000012188 paraffin wax Substances 0.000 description 22
- 239000000463 material Substances 0.000 description 21
- 239000000427 antigen Substances 0.000 description 18
- 102000036639 antigens Human genes 0.000 description 18
- 108091007433 antigens Proteins 0.000 description 18
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 12
- 230000002380 cytological effect Effects 0.000 description 12
- 239000011521 glass Substances 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000000834 fixative Substances 0.000 description 8
- 238000011065 in-situ storage Methods 0.000 description 8
- 210000002741 palatine tonsil Anatomy 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 230000002055 immunohistochemical effect Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 238000007901 in situ hybridization Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000008096 xylene Substances 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 108010090804 Streptavidin Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 4
- 238000011532 immunohistochemical staining Methods 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 101710180316 Protease 2 Proteins 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229920006397 acrylic thermoplastic Polymers 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003637 basic solution Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- VZWXNOBHWODXCW-ZOBUZTSGSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[2-(4-hydroxyphenyl)ethyl]pentanamide Chemical compound C1=CC(O)=CC=C1CCNC(=O)CCCC[C@H]1[C@H]2NC(=O)N[C@H]2CS1 VZWXNOBHWODXCW-ZOBUZTSGSA-N 0.000 description 1
- 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102100021022 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 1
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
- 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229940046836 anti-estrogen Drugs 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 239000003418 antiprogestin Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- IRPXADUBAQAOKL-UHFFFAOYSA-N chembl1408927 Chemical compound C1=CC=C2C(N=NC3=C4C=CC(=CC4=CC(=C3O)S(O)(=O)=O)S(O)(=O)=O)=CC=C(S(O)(=O)=O)C2=C1 IRPXADUBAQAOKL-UHFFFAOYSA-N 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- GRXPVLPQNMUNNX-MHJRRCNVSA-N estrane Chemical compound C1CC2CCCC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 GRXPVLPQNMUNNX-MHJRRCNVSA-N 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000007850 in situ PCR Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003963 intermediate filament Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 102000003998 progesterone receptors Human genes 0.000 description 1
- 108090000468 progesterone receptors Proteins 0.000 description 1
- 230000003623 progesteronic effect Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- GRONZTPUWOOUFQ-UHFFFAOYSA-M sodium;methanol;hydroxide Chemical compound [OH-].[Na+].OC GRONZTPUWOOUFQ-UHFFFAOYSA-M 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/36—Embedding or analogous mounting of samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
- G01N35/1002—Reagent dispensers
Definitions
- the present invention relates to a method for removing embedding media from biological samples on automated instruments prior to immunohistochemical (IHC), in situ hybridization (ISH) or other histochemical or cytochemical manipulations.
- the present invention also relates to a method for conditioning cells or tissues so as to increase the accessibility of various molecules to their respective targets and generally to improve tissue and cell readability.
- in situ techniques such as in situ hybridization and in situ polymerase chain reaction are now used to help diagnose disease states in humans.
- in situ techniques such as in situ hybridization and in situ polymerase chain reaction are now used to help diagnose disease states in humans.
- sample cells or tissues which may include fixing the sample with chemicals such as an aldehyde (such as formaldehyde, glutaraldehyde), formalin substitutes, alcohol (such as ethanol, methanol, isopropanol) or embedding the sample in inert materials such as paraffin, celloidin, agars, polymers, resins, cryogenic media or a variety of plastic embedding media (such as epoxy resins and acrylics).
- aldehyde such as formaldehyde, glutaraldehyde
- formalin substitutes such as ethanol, methanol, isopropanol
- inert materials such as paraffin, celloidin, agars, polymers, resins, cryogenic media or a variety of plastic embedding media (such as epoxy resins and acrylics).
- FNA fine needle aspiration
- tissue or cell sample or its method of preparation or preservation the goal of the technologist is to obtain accurate, readable and reproducible results that permit the accurate interpretation of the data.
- One way to provide accurate, readable and reproducible data is to prepare the tissue or cells in a fashion that optimizes the results of the test regardless of the technique employed. In the case of immunohistochemistry and in situ techniques this means increasing the amount of signal obtained from the specific probe (antibody, DNA, RNA). In the case of histochemical staining it may mean increasing the intensity of the stain or increasing staining contrast. Without preservation, tissue samples rapidly deteriorate such that their use in diagnostics is compromised shortly after removal from their host.
- the extent to which the cross-linking reaction occurs depends on conditions such as the concentration of formalin, pH, temperature and length of fixation (Fox et al., J. Histochem. Cytochem. 33: 845-853 (1985)).
- Some antigens, such as gastrin, somatostatin and ⁇ -1-antitrypsin may be detected after formalin fixation, but for many antigens, such as intermediate filaments and leukocyte markers, immunodetection after formalin treatment is lost or markedly reduced (McNicol & Richmond, Histopathology 32: 97-103 (1998)). Loss of antigen immunoreactivity is most noticeable at antigen epitopes that are discontinuous, i.e. amino acid sequences where the formation of the epitope depends on the confluence of portions of the protein sequence that are not contiguous.
- Antigen RetrievalTM is a term that describes the attempt to "undo" the structural changes that treatment of tissue with a cross-linking agent induces in the antigens resident within that tissue. Although there are several theories that attempt to describe the mechanism of Antigen RetrievalTM such as loosening or breaking of crosslinkages formed by formalin fixation, it is clear that modification of protein structure by formalin is reversible under conditions such as high-temperature heating. It is clear that several factors affect Antigen RetrievalTM: heating, pH, molarity and metal ions in solution (Shi et al., J. Histochem. Cytochem. 45: 327-343 (1997)).
- Microwave heating appears to be the most important factor for retrieval of antigens masked by formalin fixation. Microwave heating (100° ⁇ 5°C) generally yields better results in Antigen RetrievalTM immunohistochemistry (AR-IHC).
- staining enhancements may include but are not limited to distilled water, EDTA, urea, Tris, glycine, saline and citrate buffer. Solutions containing a variety of detergents (ionic or non-ionic surfactants) may also facilitate staining enhancement under a wide range of temperatures (from ambient to in excess of 100°C).
- hematology smears examples include but are not limited to a) hematology smears, cytospinsTM, ThinPrepsTM, touch preps, cell lines, Ficoll separations for lymphocytes and buffy coats etc. are routinely preserved in a many ways which include but are not limited to air-drying, alcoholic fixation, spray fixatives and storage mediums such as sucrose/glycerin storage medium, b) tissues and cells (either fixed or unfixed) may be frozen and subsequently subjected to various stabilizing techniques such preservation, fixation and desiccation, c) tissues and cells may be stabilized in a number of non-cross-linking aldehyde fixatives, non- aldehyde containing fixatives, alcoholic fixatives, oxidizing agents, heavy metal fixatives, organic acids and transport media.
- One way to improve testing results is to increase the signal obtained from a given sample.
- increased signal can be obtained by increasing the accessibility of a given molecule for its target.
- targets within the cell can be made more accessible by increasing the permeability of the cell thereby permitting a greater number of molecules entry into the cell, thereby increasing the probability that the molecule will "find" its target.
- Such increased permeability is especially important for techniques such as ISH, in situ PCR, IHC, histochemistry and cytochemistry.
- Tissues and cells are also embedded in a variety of inert media (paraffin, celloidin, OCTTM, agar, plastics or acrylics etc.) to help preserve them for future analysis.
- inert media paraffin, celloidin, OCTTM, agar, plastics or acrylics etc.
- Many of these inert materials are hydrophobic and the reagents used for histological and cytological applications are predominantly hydrophilic, therefor the inert medium may need to be removed from the biological sample prior to testing.
- paraffin embedded tissues sections are prepared for subsequent testing by removal of the paraffin from the tissue section by passing the slide through various organic solvents such as toluene, xylene, limonene or other suitable solvents.
- Traditional deparaffinization uses organic solvents, which generally requires that the process be performed in ventilated hoods.
- the methods of the present invention permit a) automated removal of embedding media without the use of organic solvents, thus exposing the cells for staining and thereby reducing time, cost and safety hazards b) automated cell conditioning without automated removal of embedding media from the sample cell or tissue, c) a multi-step automated process that exposes the cells, performs cell conditioning and increases permeability of the cytological or histological specimens, thereby increasing sample readability and improving interpretation of test data.
- the methods of the present invention can be used for improving the stainability and readability of most histological and cytological samples used in conjunction with cytological and histological staining techniques.
- the present invention relates to an automated method for exposing biological samples for use in histological or cytological testing procedures by removing the embedding media without the use of organic solvents.
- the present invention further relates to an automated method for cell conditioning, thus improving the accessibility of molecules in biological samples.
- the present invention also relates to an automated method for the simultaneous exposing and cell conditioning of biological samples for histochemical and cytochemical applications.
- One embodiment of the present invention relates to the exposing of biological samples by removal of the inert materials in which biological samples have been embedded for preservation and support.
- paraffin or other inert materials are removed from biological samples by heating one side of the biological sample. This may be accomplished by contact heating of the microscope slide on which the embedded biological samples have been placed.
- Other inert materials that can be removed from embedded biological samples include but are not limited to agars and cryogenic media. This process of removal of inert embedding media or etching of embedding media is referred to herein as exposing.
- the paraffin-embedded biological sample laying on the glass slide is first heated by a heating element.
- the heating element exposes heat on one side of the biological sample (such as the thermal platforms disclosed in U.S. patent application 09/259,240, herein incorporated by reference) within an automated staining instrument (U.S. patent application Serial No. 08/995,052 filed on December 19, 1997 and U.S. provisional patent application Serial No. 60/076,198 filed on February 27, 1998, both of which are herein incorporated by reference) such that the sample slide is dried and the paraffin is melted.
- the biological sample is placed on a top surface of a slide (such as a glass slide).
- the inert material may be removed from the slide by a fluid (as a gas or liquid).
- a fluid as a gas or liquid
- the inert material may be rinsed with DI water and a surfactant.
- a paraffin embedded biological sample is placed on a glass microscope slide and the microscope slide is placed on a heating element.
- a reagent is placed on the biological sample slide, the biological sample slide is then exposed to elevated temperatures that will permit the melting of the inert material, and after which the inert material may be removed from the slide by a fluid (as a gas or liquid).
- reagents are used in conjunction with heating the embedded biological samples.
- Suitable reagents may include, but are not limited to, de-ionized water, citrate buffer (pH 6.0-8.0), Tris-HCl buffer (pH 6-10), phosphate buffer (pH 6.0-8.0), SSC buffer, APK WashTM, acidic buffers or solutions (pH 1-6.9), basic buffers or solutions (pH 7.1-14), mineral oil, Norpar, canola oil, and PAG oil.
- Each of these reagents may also contain ionic or non- ionic surfactants such as Triton X-100, Tween, Brij, saponin and sodium dodecylsulfate.
- the temperature of the heating element is raised to a temperature in excess of the melting point of the inert material.
- the melting point of pure paraffin is listed as 50-57° C in the Merck index.
- the temperature is in excess of the melting point of the paraffin in which the biological sample is embedded.
- the temperature is raised in excess of 50° C to about 130° C.
- the duration of time required to melt the inert material will vary according to the temperature used and the embedding material.
- a processor such as a microprocessor, is used in conjunction with a memory.
- the amount of time and the temperature required to melt the paraffin is contained within a table contained in the memory.
- the paraffin embedded biological sample is subjected to elevated temperatures ranging from 5 minutes to 60 minutes.
- the heating element used in the method of the present invention requires that sufficient contact be maintained between the surface on which the biological sample is placed and the heating element.
- Another embodiment of the present invention relates to the exposing of biological samples without removal of the inert materials in which biological samples have been embedded for preservation and support.
- biological samples are readied for testing by contact heating of the microscope slide on which the embedded biological samples have been placed.
- Other inert materials that are not removed from embedded biological samples include but are not limited to plastic or celloidin embedding media and/or other polymers and resins.
- the embedded biological sample laying on the glass slide is first heated by the heating element.
- the heating element exposes heat on one side of the biological sample, such as by using the thermal platforms disclosed in U.S. patent application 09/259,240 within an automated staining instrument (U.S. patent applications 08/995,052 and 60/076,198) such that the sample slide is dried.
- an embedded biological sample is placed on a glass microscope slide and the microscope slide is heated on one side (e.g., by placing the slide on a thermal platform).
- a reagent is then placed on the biological sample slide and the biological sample slide, with the reagent, is then heated to a specified temperature (ranging from ambient to greater than 100°C) and for a specified amount of time (ranging from 2 minutes to 12 hours). This will cause etching of the surface of the inert embedding material, and after which the etching reagent may be removed from the slide by a fluid (as a gas or liquid).
- a fluid as a gas or liquid
- reagents are used in conjunction with or without heating the embedded biological samples.
- Suitable reagents may include, but are not limited to, de-ionized water, citrate buffer (pH 6.0-8.0), Tris- HC1 buffer (pH 6-10), phosphate buffer (pH 6.0-8.0), SSC buffer, APK WashTM, acidic buffers or solutions (pH 1-6.9), basic buffers or solutions (pH7.1-14) mineral oil, Norpar, canola oil, and PAG oil.
- Each of these reagents may also contain ionic or non- ionic surfactants such as Triton X-100, Tween, Brij, saponin and sodium dodecylsulfate.
- the temperature of the heating element is set to an appropriate level for the drying or the etching of the embedded biological sample.
- etching may be carried out with a basic solution of methanol sodium hydroxide (sodium methoxide) at temperatures ranging from ambient to 37°C.
- the duration of time required to etch the inert material will vary according to the temperature used and the embedding material (plastic or celloidin embedding media and/or other polymers and resins etc.).
- the embedded biological sample is subjected to appropriate temperatures ranging from 2 minutes to 12 hours.
- the heating element used in the method of the present invention requires that sufficient contact be maintained between the surface on which the biological sample is placed and the heating element.
- a preferred embodiment present invention also comprises an automated method of cell conditioning, either concurrent with, subsequent to or independent of removal or etching of the inert embedding material from the biological sample.
- Heating the biological sample in an appropriate (organic or inorganic) reagent has been found to improve the accessibility of the reagent to the target molecule in the cell (protein, nucleic acid, carbohydrate, lipid, pigment or other small molecule).
- This process of improving accessibility of the reagent (organic or inorganic) to the molecular target is referred to herein as cell conditioning.
- cell conditioning is accomplished while the biological sample is being exposed as described above.
- a biological sample is placed on a glass microscope slide and the microscope slide is heated on one side (e.g., by placing the slide on a thermal platform) within an automated staining instrument (U.S. patent applications 08/995,052 and 60/076,198).
- a reagent is placed on the biological sample and the temperature of the heating element may or may not be increased.
- the biological sample is exposed to the appropriate temperature for an appropriate duration of time that will permit the melting or etching of the inert material and permit cell conditioning of the biological sample to be subsequently stained using histological or cytological techniques.
- a cell conditioning solution may be a solution of EDTA; a common temperature setting may be 95°C for a duration ranging from 6-60 minutes.
- a cell conditioning solution may be a solution of boric acid buffer; a common temperature setting may be in excess of 100°C for a duration ranging from 6-60 minutes.
- a cell conditioning solution may be a solution of SSC; a common temperature setting may be 75°C for a duration ranging from 6-60 minutes.
- a cell conditioning solution may be treated de- ionized water; a common temperature may range from 60-80°C for a duration of 6-30 minutes.
- the solutions should generally be of known molarity, pH, and composition.
- Sodium dodecyl sulfate (SDS), ethylene glycol is preferably added to the conditioning solution.
- metal ions or other materials may be added to these reagents to increase effectiveness of the cell conditioning.
- cell conditioning is accomplished subsequent to the biological sample being exposed as described above.
- a biological sample is placed on a glass microscope slide and the microscope slide is heated on one side (e.g., by placing the slide on a thermal platform) within an automated staining instrument (U.S. patent applications 08/995,052 and 60/076,198).
- the embedded biological sample laying on the glass slide is first heated by the heating element within an automated staining instrument such that the sample slide is dried and the embedding material is melted or etched and removed by the application of a fluid.
- an appropriate reagent is applied in order to permit cell conditioning of the biological sample to be subsequently stained using histological or cytological techniques.
- a cell conditioning solution may be a solution of SSC; a common temperature setting may be 95°C for a duration ranging from 6-60 minutes.
- a cell conditioning solution may be a solution of Phosphate buffer; a common temperature setting may be in excess of 100°C for a duration ranging from 6-60 minutes.
- a cell conditioning solution may be a solution of SSC; a common temperature setting may be 75°C for a duration ranging from 6-60 minutes.
- a cell conditioning solution may be Bouins; a common temperature may range from 60-80°C for a duration of 6-30 minutes.
- cell conditioning is accomplished without the biological sample being exposed.
- a biological sample is placed on a glass microscope slide and the microscope slide placed on a heating element within an automated staining instrument.
- a reagent is placed on the biological sample and the temperature of the heating element may or may not be increased.
- Cell conditioning of the biological sample may be performed prior to being stained using histological or cytological techniques.
- a cell conditioning solution may be a solution of Sodium Citrate; a common temperature setting may be 90°C for a duration ranging from 6-60 minutes.
- a cell conditioning solution may be a solution of urea; a common temperature setting may be in excess of 100°C for a duration ranging from 6-60 minutes.
- a cell conditioning solution may be a solution of methanol; a common temperature setting may be ambient for a duration ranging from 4-10 minutes.
- a cell conditioning solution may be peanut oil; a common temperature may range from 60-70°C for a duration of 30-60 minutes.
- the present invention also comprises cell conditioning of cytological preps, such as fine needle aspirations (FNA) smears, touch preps, Ficoll, Cytospins ® , Thins Preps ® , cervical-vaginal pap smears, blood or body fluid films, etc., that are neither fixed with an aldehyde nor embedded in a matrix, such as paraffin.
- cytological fixatives such as fine needle aspirations (FNA) smears, touch preps, Ficoll, Cytospins ® , Thins Preps ® , cervical-vaginal pap smears, blood or body fluid films, etc.
- the cells are either centrifuged or filtered to a slide or directly touched to a glass slide and smeared in some cases (PAP's) or applied directly against the slide (touch preps).
- PAP's centrifuged or filtered to a slide or directly touched to a glass slide and smeared in some cases (PAP's) or applied directly against the slide (touch preps).
- Biological sample is meant any collection of cells (either loose or in tissue) that can be mounted on a standard glass microscope slide including, without limitation, sections of organs, tumors sections, bodily fluids, smears, frozen sections, blood, cytology preps, microorganisms and cell lines.
- Stain is meant any biological or chemical entity which, when applied to targeted molecules in biological sample, renders the molecules detectable under microscopic examination.
- Stains include without limitation detectable nucleic acid probes, antibodies, and other reagents which in combination or by themselves result in a colored end product (by bright field or fluorescence).
- the following examples are presented for illustrative purposes only and are not intended, nor should they be construed, as limiting the invention in any way. Those skilled in the art will recognize that variations on the following can be made without exceeding the spirit or scope of the invention. All patents, patent applications, and other publications are hereby incorporated by reference in their entirety.
- Example 1 Automated "Exposing” and “Cell Conditioning” with Biological Samples Stained with H&E Biological samples, including breast CHTN33, stomach 149G, brain, tonsil and kidney, that had been embedded in paraffin were exposed according to the following procedure: slides containing the above referenced biological sample were placed on an automated instrument (Ventana Medical Systems, Inc., Arlington, AZ) and subjected to the exposing protocol described below.
- the biological sample was stained with hematoxylin and eosin by the following method. Slides were placed in hematoxylin 1 (Richard Allen Scientific, Kalamazoo, MI) for 1.5 minutes and then rinsed with running de-ionized water for one minute. Slides were then placed in acid alcohol clarifier (Richard Allen Scientific) for one minute and then rinsed with running de-ionized water for one minute. Slides were then placed in diluting ammonia-bluing reagent for one minute (Richard Allen Scientific, Kalamazoo, MI) and then rinsed in running de-ionized water for one minute.
- Control biological samples were deparaffmized by a traditional solvent-based deparaffmization technique.
- Biological sample place on microscope slides and preserved in paraffin were completely submersed in a xylene bath for five minutes.
- Slides containing biological sample were placed in a second xylene bath for five minutes. After removal from the second xylene bath, the slides were placed in a 100% ethanol bath for three minutes. Slides were then placed in a second 100% ethanol bath for three minutes and then placed in a 90% ethanol solution for two minutes. The slides were then placed in 80% ethanol for one minute followed by complete immersion in distilled water for one to three minutes.
- the biological samples were stained with hematoxylin and eosin as described above.
- the biological samples that were deparaffmized by the solvent technique and by the automated heating technique were compared after staining by hematoxylin and eosin. Morphology on all sets of slide was acceptable and essentially equivalent.
- the tonsil and brain biological samples that were exposed by the automated heating method showed more intensified hematoxylin staining than the biological samples deparaffmized by standard solvent techniques.
- Example 2 Automated "Exposing" of Biological e Samples with Simultaneous "Cell Conditioning” Biological samples of kidney Q-10 and tonsil T998D that had been formalin fixed and embedded in paraffin were exposed according to the protocol described in Example 1. After automated exposing, the biological sample was subjected to the DAB paraffin protocol used for immunohistochemical staining. The protocol for DAB staining is described below:
- the primary antibody used for the kidney Q-10 biological sample was Anti-
- CD15 (Nentana Medical Systems, Inc. Arlington, AZ, Catalogue no. 250-2504).
- the primary antibody used for the tonsil T998D biological sample was Anti-CD45RO
- Control biological samples were deparaffmized by a traditional solvent-based deparaffmization technique, as described in Example 1. After deparaffmization the biological samples were placed in a pressure cooker (Model #62104 Nordic Ware, Minneapolis, MN) containing 1.5 L lx citrate buffer. The pressure cooker was then sealed and placed in a microwave oven (Model #MQSO836E, Matsushita, Franklin Park, IL). With the microwave oven set on “high,” the samples were subjected to microwave heating for approximately 30 minutes. After microwaving the samples were then "cured” for 30 minutes in the pressure cooker with the lid securely fastened. After curing the biological samples were placed in lx citrate buffer for two minutes.
- the biological samples were then removed from the citrate buffer and the end of the slides blotted to removed excess citrate buffer. After blotting, the slides were placed on the automated instrument and immunohistochemically stained as described above. The biological samples deparaffmized by the solvent technique and by the automated exposing and simultaneous cell conditioning technique were compared after immunohistochemical staining. Morphology on all sets of slide was acceptable and essentially equivalent.
- thermofoil temperature 100.0° C
- Example 2 was treated with anti-Ki67 as a primary antibody.
- Samples E68, E7, E33, and E8 biological sample was treated with anti-estrogen receptor (6F11) as a primary antibody.
- E29, E15, and E68 biological sample was treated with anti- progesterone receptor (1 A6) as a primary antibody.
- Control biological samples were deparaffmized by a traditional solvent-based de-paraffmization technique, as described in Example 1. After deparaffmization the biological samples were placed in a pressure cooker (Model #62104 Nordic Ware, Minneapolis, MN) containing 1.5 L lx citrate buffer. The pressure cooker was then sealed and placed in a microwave oven (Model #MQSO836E, Matsushita, Franklin Park, IL). With the microwave oven set on "high”, the samples were subjected to microwave heating for approximately 30 minutes. After microwaving the samples were then "cured” for 30 minutes in the pressure cooker with the lid securely fastened. After curing the biological samples were placed in lx citrate buffer for two minutes.
- the biological samples were then removed from the citrate buffer and the end of the slides were blotted to removed excess citrate buffer. After blotting the slide were placed on the automated instrument and immunohistochemically stained as described above. The biological samples deparaffmized by solvent technique and by the automated heating technique were compared after immunohistochemical staining. Morphology on all sets of slide was acceptable and essentially equivalent.
- Hela (lot # 980427H), Caski (lot # 980416C) and Siha (lot # 980416S) cell lines stored in Cytyk preparation solution (lot # 01139Q) were deposited on microscope slides using the Cytyk 2000 instrument. After deposition the slides were placed in alcohol to keep moist until use on the Discovery® In-Situ staining module (Ventana).
- the cell lines were stained for HPV 16/18 (Enzo HPV 16/18 Bio Probe cat # 32874). Prior to probe application the cell lines are enzymatically digested with Protease 2 (Ventana P/N 250-2019). After the probe application the probe and biological sample are denatured simultaneously at 95° C for 8 minutes. The non-specifically bound probe is washed off with stringency washes of 2 X SSC at 55° C. The probe is then detected with Streptavidin Alk Phos and NBT/BCIP.
- the cell lines were dehydrated after staining with a one-minute exposure to 95 % ethanol and a one-minute exposure to 100% ethanol repeated 2 times. Following the ethanol the slides were exposed to xylene for 3 minutes twice. After dehydration the slides were coverslipped.
- the stained cell lines after conditioning showed acceptable morphology, there was high background on these slides indicating a need for the process to be developed more.
- Example 5 Automated "Exposing” and “Cell Conditioning” for single copy DNA detection Slides containing formalin fixed, paraffin embedded cell lines Caski (R96- 1050A) and Siha (R96-96-C2) were stained on Ventana target slides. Slides were dry loaded onto the instrument and the slide temperature was increased to 65° C. Depar 30 protocol was run where the slides are rinsed with 2x SSC Buffer while at 65° C then the heat is increased to 95° C for about 40 minutes. The slides were then cooled to 37° C and rinsed with APK wash. At this time the following In Situ protocol was run: In-Situ Protocol: Tubbs 1 (Dako TBST # 3306 is substituted for Ventana APK Wash during non-probe steps)
- Protease Digestion Protease 2, 4 minutes, 37 °C Inhibitor Step: Ventana Inhibitor from DAB kit 32 minutes 37° C
- Streptavidin HRPO Dako GenPoint #K0620
- the cell conditioning steps for these antibodies was done after using a Cytyk 2000® instrument to make ThinPreps ® of cell lines.
- the ThinPreps ® were stained using antibodies to ER, PgR, Ki67, P53 on Ventana ES instruments, NexES instruments and a manual procedure (Cytyk, Inc.).
- a duplicate group of slides have been stained on the NesES Insitu module, allowing the cell conditioning steps to be performed by automation.
- Frozen tonsil blocks 297C and 297D were prepared by cutting six sections from each block and placing the sample on microscope slides. Four slides from each block were placed on the DiscoveryTM Insitu module and put through protocol Depar 10.
- Slides are dry heated to 65° for 6 minutes then rinsed with 0.1M EDTA buffer pH 8. After rinsing, the slide is incubated at 65° for 20 minutes. Slides were then cooled to 37° C and rinsed with APK Wash. Two slides from each block were left untreated as controls. Following the Depar 10 treatment two treated slides from each block and one untreated slide were stained for H & E as described in Example 1. Two treated slides from each block and one untreated from each block are stained for LCA. Run outcomes: for both the H & E and antibody staining there was no staining difference between the treated and untreated slides.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002341421A CA2341421C (en) | 1998-09-03 | 1999-09-03 | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
EP99945510.8A EP1112479B1 (en) | 1998-09-03 | 1999-09-03 | Automated removal of embedding media from biological samples |
AU58097/99A AU766614B2 (en) | 1998-09-03 | 1999-09-03 | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
JP2000569205A JP3782663B2 (en) | 1998-09-03 | 1999-09-03 | Removal of embedding media from biological samples and cell conditioning in automated staining equipment |
US09/721,096 US6855559B1 (en) | 1998-09-03 | 2000-11-22 | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
US09/800,689 US6855552B2 (en) | 1998-09-03 | 2001-03-07 | Automated immunohistochemical and in situ hybridization assay formulations |
US09/853,200 US6544798B1 (en) | 1999-02-26 | 2001-05-11 | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
US10/471,126 US7550298B2 (en) | 1998-09-03 | 2002-03-07 | Automated immunohistochemical and in situ hybridization assay formulations |
US10/320,219 US7067325B2 (en) | 1998-02-27 | 2002-12-16 | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
US10/394,996 US7410753B2 (en) | 1998-09-03 | 2003-03-21 | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
AU2004200259A AU2004200259A1 (en) | 1998-09-03 | 2004-01-23 | Removal of Embedding Media from Biological Samples and Cell Conditioning on Automated Staining Instruments |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9901898P | 1998-09-03 | 1998-09-03 | |
US60/099,018 | 1998-09-03 | ||
US09/259,240 | 1999-02-26 | ||
US09/259,240 US6296809B1 (en) | 1998-02-27 | 1999-02-26 | Automated molecular pathology apparatus having independent slide heaters |
PCT/US1999/004181 WO1999044030A1 (en) | 1998-02-27 | 1999-02-26 | Automated molecular pathology apparatus having independent slide heaters |
USPCT/US99/04181 | 1999-02-26 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/259,240 Continuation US6296809B1 (en) | 1998-02-27 | 1999-02-26 | Automated molecular pathology apparatus having independent slide heaters |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/004181 Continuation WO1999044030A1 (en) | 1998-02-27 | 1999-02-26 | Automated molecular pathology apparatus having independent slide heaters |
US09/721,096 Continuation US6855559B1 (en) | 1998-02-27 | 2000-11-22 | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000014507A1 true WO2000014507A1 (en) | 2000-03-16 |
Family
ID=27378706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/020353 WO2000014507A1 (en) | 1998-02-27 | 1999-09-03 | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1112479B1 (en) |
JP (1) | JP3782663B2 (en) |
CN (1) | CN100389314C (en) |
AU (1) | AU766614B2 (en) |
WO (1) | WO2000014507A1 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002042737A2 (en) * | 2000-11-22 | 2002-05-30 | Ventana Medical Systems, Inc. | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
WO2002023157A3 (en) * | 2000-09-13 | 2003-10-30 | Shandon Inc | Method and device for melting embedding medium |
JP2004515752A (en) * | 2000-09-15 | 2004-05-27 | バイオジェネックス ラボラトリーズ | Improve in situ hybridization |
WO2004086001A1 (en) * | 2003-03-21 | 2004-10-07 | Ventana Medical Systems, Inc. | Simultaneous removal of embedding media and fixation of biological samples on automated instruments for sample preparation |
US6933117B2 (en) * | 2001-04-30 | 2005-08-23 | Ventana Medical Systems, Inc. | Reagents and methods for automated hybridization |
US7250301B2 (en) | 1999-07-08 | 2007-07-31 | Lee Angros | In situ heat induced antigen recovery and staining method |
JP2008197115A (en) * | 2002-04-15 | 2008-08-28 | Ventana Medical Systems Inc | Automated high volume slide staining system |
US20080261266A1 (en) * | 2004-12-17 | 2008-10-23 | Ventana Medical Systems, Inc. | Methods and compositions for a microemulsion-based tissue treatment |
US7550298B2 (en) | 1998-09-03 | 2009-06-23 | Ventana Medical Systems, Inc. | Automated immunohistochemical and in situ hybridization assay formulations |
US7897106B2 (en) | 1999-07-08 | 2011-03-01 | Lee Angros | Situ heat induced antigen recovery and staining apparatus and method |
WO2012117294A2 (en) | 2011-02-28 | 2012-09-07 | Dako Denmark A/S | Two phase immiscible system for the pretreatment of embedded biological samples |
US8298485B2 (en) | 1999-07-08 | 2012-10-30 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US9267868B2 (en) | 2008-08-29 | 2016-02-23 | Lee H. Angros | In Situ heat induced antigen recovery and staining apparatus and method |
US9354145B2 (en) | 2005-05-24 | 2016-05-31 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US9645056B2 (en) | 2010-02-05 | 2017-05-09 | Nichirei Biosciences, Inc. | Pretreatment solution for immunohistochemical staining and condensed solution thereof |
CN110050070A (en) * | 2016-12-22 | 2019-07-23 | 文塔纳医疗系统公司 | Full-automatic method for extracting nucleic acid for tissue sample |
US10416176B2 (en) | 2013-12-13 | 2019-09-17 | Ventana Medical Systems, Inc. | Staining reagents and other liquids for histological processing of biological specimens and associated technology |
US10495654B2 (en) | 2013-12-13 | 2019-12-03 | Ventana Medical Systems, Inc. | Thermal management in the context of automated histological processing of biological specimens and associated technology |
CN112945657A (en) * | 2021-01-22 | 2021-06-11 | 中国科学院东北地理与农业生态研究所 | Pretreatment device and method for preparing plant material paraffin section |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7186522B2 (en) * | 2003-03-31 | 2007-03-06 | Cytyc Corporation | Papanicolau staining process |
JP4512765B2 (en) * | 2005-03-22 | 2010-07-28 | 独立行政法人理化学研究所 | Pretreatment liquid for biological tissue section and method for observing nucleic acid and protein in biological tissue using the same |
EP2546628A1 (en) * | 2011-07-13 | 2013-01-16 | Koninklijke Philips Electronics N.V. | Filter support with a phase-changing medium |
US20130203109A1 (en) * | 2012-01-26 | 2013-08-08 | Leica Biosystems Richmond, Inc. | Methods and Compositions for Hematoxylin and Eosin Staining |
EP2817606B1 (en) * | 2012-02-24 | 2021-06-02 | Instrunor AS | Instrument for pretreating cell samples |
CA2983930C (en) * | 2016-04-15 | 2023-05-02 | Sakura Finetek U.S.A., Inc. | Methods to reduce evaporation during elevated temperature |
CN106442070B (en) * | 2016-11-30 | 2019-04-12 | 湖南农业大学 | A kind of production method of plant leaf blade slice |
WO2018169651A1 (en) * | 2017-03-16 | 2018-09-20 | Siemens Healthcare Diagnostics Inc. | System and method for thermal control of incubation system in diagnostic analyzer |
WO2020041781A1 (en) * | 2018-08-23 | 2020-02-27 | Essenlix Corporation | Enhanced, rapid, homogeneous, cell staining and assay |
CN109975095A (en) * | 2019-02-22 | 2019-07-05 | 嘉兴雅康博医学检验所有限公司 | A kind of pretreatment liquid and pre-treating method of fluorescence in situ hybridization |
CA3166408A1 (en) * | 2019-12-31 | 2021-07-08 | Sakura Finetek U.S.A., Inc. | Automated staining system and reaction chamber |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4043292A (en) * | 1975-07-21 | 1977-08-23 | Corning Glass Works | Microscope slide staining apparatus having temperature control |
US5023187A (en) * | 1985-09-13 | 1991-06-11 | Fisher Scientific Company | Method and device for accelerated treatment of thin sample on surface |
US5273905A (en) * | 1991-02-22 | 1993-12-28 | Amoco Corporation | Processing of slide mounted material |
US5614376A (en) * | 1994-10-20 | 1997-03-25 | Dicin Resources, Inc. | Method for facilitating tissue slide preparation |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US518795A (en) * | 1894-04-24 | staples | ||
US5187099A (en) * | 1986-10-29 | 1993-02-16 | Coulter Corporation | Control slide for immunoassay kit using a low-temperature melting paraffin |
US5244787A (en) * | 1991-01-31 | 1993-09-14 | Biogenex Laboratories | Antigen retrieval in formalin-fixed tissues using microwave energy |
WO1992019952A1 (en) * | 1991-05-07 | 1992-11-12 | Wescor, Inc. | Improved staining method for histology and cytology specimens |
ES2173894T3 (en) * | 1992-08-12 | 2002-11-01 | Biogenex Lab | INCREMENT OF IMMUNOLOCHEMICAL COLORATION IN FABRICS FIXED BY ALDEHIDO. |
DE69410084T2 (en) * | 1993-02-03 | 1999-01-21 | Histaggen Inc., Bowmanville, Ontario | AUTOMATED HISTO-CYTOCHEMICAL DEVICE AND ENCLOSURE SYSTEM FOR TREATING BIOLOGICAL MATERIAL |
US5344637A (en) * | 1993-06-01 | 1994-09-06 | Camiener Gerald W | Use of saturated, ring-containing compounds as clearing solvents in histologic procedures |
US5439649A (en) * | 1993-09-29 | 1995-08-08 | Biogenex Laboratories | Automated staining apparatus |
US6632598B1 (en) * | 1994-03-11 | 2003-10-14 | Biogenex Laboratories | Deparaffinization compositions and methods for their use |
-
1999
- 1999-09-03 JP JP2000569205A patent/JP3782663B2/en not_active Expired - Lifetime
- 1999-09-03 WO PCT/US1999/020353 patent/WO2000014507A1/en active IP Right Grant
- 1999-09-03 EP EP99945510.8A patent/EP1112479B1/en not_active Expired - Lifetime
- 1999-09-03 CN CNB998106259A patent/CN100389314C/en not_active Expired - Lifetime
- 1999-09-03 AU AU58097/99A patent/AU766614B2/en not_active Expired
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4043292A (en) * | 1975-07-21 | 1977-08-23 | Corning Glass Works | Microscope slide staining apparatus having temperature control |
US5023187A (en) * | 1985-09-13 | 1991-06-11 | Fisher Scientific Company | Method and device for accelerated treatment of thin sample on surface |
US5273905A (en) * | 1991-02-22 | 1993-12-28 | Amoco Corporation | Processing of slide mounted material |
US5614376A (en) * | 1994-10-20 | 1997-03-25 | Dicin Resources, Inc. | Method for facilitating tissue slide preparation |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7410753B2 (en) | 1998-09-03 | 2008-08-12 | Ventana Medical Systems, Inc. | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
US7550298B2 (en) | 1998-09-03 | 2009-06-23 | Ventana Medical Systems, Inc. | Automated immunohistochemical and in situ hybridization assay formulations |
US6544798B1 (en) | 1999-02-26 | 2003-04-08 | Ventana Medical Systems, Inc. | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
US8574494B2 (en) | 1999-07-08 | 2013-11-05 | Lee Angros | In situ heat induced antigen recovery and staining method |
US8007721B2 (en) | 1999-07-08 | 2011-08-30 | Lee Angros | In Situ heat induced antigen recovery and staining apparatus and method |
US10416052B2 (en) | 1999-07-08 | 2019-09-17 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US8354058B2 (en) | 1999-07-08 | 2013-01-15 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US7250301B2 (en) | 1999-07-08 | 2007-07-31 | Lee Angros | In situ heat induced antigen recovery and staining method |
US8329100B2 (en) | 1999-07-08 | 2012-12-11 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US10281375B2 (en) | 1999-07-08 | 2019-05-07 | Lee H. Angros | In situ heat induced antigen recovery and staining method |
US9976941B2 (en) | 1999-07-08 | 2018-05-22 | Lee H. Angros | In situ heat induced antigen recovery and staining method |
US7476362B2 (en) | 1999-07-08 | 2009-01-13 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US8313694B2 (en) | 1999-07-08 | 2012-11-20 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US7622077B2 (en) | 1999-07-08 | 2009-11-24 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US7632461B2 (en) | 1999-07-08 | 2009-12-15 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US7897106B2 (en) | 1999-07-08 | 2011-03-01 | Lee Angros | Situ heat induced antigen recovery and staining apparatus and method |
US8298485B2 (en) | 1999-07-08 | 2012-10-30 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US8007720B2 (en) | 1999-07-08 | 2011-08-30 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US8052927B2 (en) | 1999-07-08 | 2011-11-08 | Lee Angros | In situ heat induced antigen recovery and staining method |
US9772266B2 (en) | 1999-07-08 | 2017-09-26 | Lee H. Angros | In situ heat induced antigen recovery and staining method |
US9606034B2 (en) | 1999-07-08 | 2017-03-28 | Lee H. Angros | In situ heat induced antigen recovery and staining method |
US8071023B2 (en) | 1999-07-08 | 2011-12-06 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US8696988B2 (en) | 1999-07-08 | 2014-04-15 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US8092742B2 (en) | 1999-07-08 | 2012-01-10 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US9464974B2 (en) | 1999-07-08 | 2016-10-11 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US9176033B2 (en) | 1999-07-08 | 2015-11-03 | Lee H. Angros | In situ heat induced antigen recovery and staining method |
WO2002023157A3 (en) * | 2000-09-13 | 2003-10-30 | Shandon Inc | Method and device for melting embedding medium |
JP2004515752A (en) * | 2000-09-15 | 2004-05-27 | バイオジェネックス ラボラトリーズ | Improve in situ hybridization |
WO2002042737A2 (en) * | 2000-11-22 | 2002-05-30 | Ventana Medical Systems, Inc. | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
WO2002042737A3 (en) * | 2000-11-22 | 2002-08-01 | Ventana Med Syst Inc | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
US6933117B2 (en) * | 2001-04-30 | 2005-08-23 | Ventana Medical Systems, Inc. | Reagents and methods for automated hybridization |
JP2008197115A (en) * | 2002-04-15 | 2008-08-28 | Ventana Medical Systems Inc | Automated high volume slide staining system |
WO2004086001A1 (en) * | 2003-03-21 | 2004-10-07 | Ventana Medical Systems, Inc. | Simultaneous removal of embedding media and fixation of biological samples on automated instruments for sample preparation |
US8652803B2 (en) | 2004-12-17 | 2014-02-18 | Ventana Medical Systems, Inc. | Methods and compositions for a microemulsion-based tissue treatment |
EP2392909A1 (en) * | 2004-12-17 | 2011-12-07 | Ventana Medical Systems, Inc. | Methods and compositions for a microemulsion-based tissue treatment |
US8288121B2 (en) * | 2004-12-17 | 2012-10-16 | Ventana Medical Systems, Inc. | Methods and compositions for a microemulsion-based tissue treatment |
EP2390647A1 (en) * | 2004-12-17 | 2011-11-30 | Ventana Medical Systems, Inc. | Methods and compositions for a microemulsion-based tissue treatment |
US8512978B2 (en) | 2004-12-17 | 2013-08-20 | Ventana Medical Systems, Inc. | Methods and compositions for a microemulsion-based tissue treatment |
EP2390648A1 (en) * | 2004-12-17 | 2011-11-30 | Ventana Medical Systems, Inc. | Methods and compositions for a microemulsion-based tissue treatment |
US20080261266A1 (en) * | 2004-12-17 | 2008-10-23 | Ventana Medical Systems, Inc. | Methods and compositions for a microemulsion-based tissue treatment |
US11585737B2 (en) | 2005-05-24 | 2023-02-21 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US9354145B2 (en) | 2005-05-24 | 2016-05-31 | Lee Angros | In situ heat induced antigen recovery and staining apparatus and method |
US10697868B2 (en) | 2005-05-24 | 2020-06-30 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US9719895B2 (en) | 2005-05-24 | 2017-08-01 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US10281376B2 (en) | 2008-08-29 | 2019-05-07 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US10048177B2 (en) | 2008-08-29 | 2018-08-14 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US9766165B2 (en) | 2008-08-29 | 2017-09-19 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US11668629B2 (en) | 2008-08-29 | 2023-06-06 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US9267868B2 (en) | 2008-08-29 | 2016-02-23 | Lee H. Angros | In Situ heat induced antigen recovery and staining apparatus and method |
US10386275B2 (en) | 2008-08-29 | 2019-08-20 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US10768079B2 (en) | 2008-08-29 | 2020-09-08 | Lee H. Angros | In situ heat induced antigen recovery and staining apparatus and method |
US9645056B2 (en) | 2010-02-05 | 2017-05-09 | Nichirei Biosciences, Inc. | Pretreatment solution for immunohistochemical staining and condensed solution thereof |
WO2012117294A2 (en) | 2011-02-28 | 2012-09-07 | Dako Denmark A/S | Two phase immiscible system for the pretreatment of embedded biological samples |
US10295442B2 (en) | 2011-02-28 | 2019-05-21 | Dako Denmark A/S | Two phase immiscible system for the pretreatment of embedded biological samples |
US10495654B2 (en) | 2013-12-13 | 2019-12-03 | Ventana Medical Systems, Inc. | Thermal management in the context of automated histological processing of biological specimens and associated technology |
US10416176B2 (en) | 2013-12-13 | 2019-09-17 | Ventana Medical Systems, Inc. | Staining reagents and other liquids for histological processing of biological specimens and associated technology |
CN110050070A (en) * | 2016-12-22 | 2019-07-23 | 文塔纳医疗系统公司 | Full-automatic method for extracting nucleic acid for tissue sample |
CN110050070B (en) * | 2016-12-22 | 2023-12-22 | 文塔纳医疗系统公司 | Full-automatic nucleic acid extraction method for tissue samples |
CN112945657A (en) * | 2021-01-22 | 2021-06-11 | 中国科学院东北地理与农业生态研究所 | Pretreatment device and method for preparing plant material paraffin section |
CN112945657B (en) * | 2021-01-22 | 2023-08-25 | 中国科学院东北地理与农业生态研究所 | Pretreatment device and method for preparing plant material paraffin section |
Also Published As
Publication number | Publication date |
---|---|
AU766614B2 (en) | 2003-10-23 |
AU5809799A (en) | 2000-03-27 |
CN1317085A (en) | 2001-10-10 |
CN100389314C (en) | 2008-05-21 |
JP3782663B2 (en) | 2006-06-07 |
JP2003526086A (en) | 2003-09-02 |
EP1112479B1 (en) | 2018-08-15 |
EP1112479A4 (en) | 2003-04-02 |
EP1112479A1 (en) | 2001-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU766614B2 (en) | Removal of embedding media from biological samples and cell conditioning on automated staining instruments | |
DK1337831T3 (en) | REMOVAL OF BIOLOGICAL SAMPLING AND CELL CONDITIONING MEDIA ON AUTOMATIC DYING INSTRUMENTS | |
US6855559B1 (en) | Removal of embedding media from biological samples and cell conditioning on automated staining instruments | |
US6855552B2 (en) | Automated immunohistochemical and in situ hybridization assay formulations | |
US7410753B2 (en) | Removal of embedding media from biological samples and cell conditioning on automated staining instruments | |
AU2002220169A1 (en) | Removal of Embedding Media from Biological Samples and Cell Conditioning on Automated Staining Instruments | |
US7550298B2 (en) | Automated immunohistochemical and in situ hybridization assay formulations | |
AU2008220769A2 (en) | Fixation of a biological material | |
WO1999009390A1 (en) | A high quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation method | |
JP2005221511A (en) | Removal of embedding medium from biological sample and cell conditioning on automated staining instrument | |
AU2006202931A1 (en) | Automated immunohistochemical and in situ hybridization assay formulations | |
AU2004200259A1 (en) | Removal of Embedding Media from Biological Samples and Cell Conditioning on Automated Staining Instruments | |
MXPA01001728A (en) | Removal of embedding media from biological samples and cell conditioning on automated staining instruments | |
Schichnes et al. | Microwave paraffin techniques for botanical tissues | |
Bratthauer | Processing of tissue specimens | |
US20230407379A1 (en) | Electric field aided sample preparation | |
AU2002247300A1 (en) | Automated immunohistochemical and in situ hybridzation assay formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99810625.9 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09721096 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/001728 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2341421 Country of ref document: CA Ref document number: 2341421 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2000 569205 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 58097/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999945510 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999945510 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10394996 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 58097/99 Country of ref document: AU |